Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000546
Filing Date
2020-02-27
Accepted
2020-02-27 20:29:07
Documents
1
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 form4-02272020_050253.html 4  
1 form4-02272020_050253.xml 4 3909
  Complete submission text file 0001415889-20-000546.txt   5375
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 800 W. OLYMPIC BLVD SUITE 406 LOS ANGELES CA 90015
Business Address
Friedman Mark J (Reporting) CIK: 0001590024 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37752 | Film No.: 20665154